ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,228 | 0.0% | 44,692 | 0.0% | 0.00% | – |
| Q2 2023 | $61,228 | -41.9% | 44,692 | 0.0% | 0.00% | – |
| Q1 2023 | $105,473 | -49.1% | 44,692 | -50.0% | 0.00% | – |
| Q4 2022 | $207,370 | +68.6% | 89,384 | +100.0% | 0.00% | – |
| Q3 2022 | $123,000 | +12.8% | 44,692 | 0.0% | 0.00% | – |
| Q2 2022 | $109,000 | -38.1% | 44,692 | 0.0% | 0.00% | – |
| Q1 2022 | $176,000 | -1.1% | 44,692 | +10.5% | 0.00% | – |
| Q4 2021 | $178,000 | -28.8% | 40,435 | 0.0% | 0.00% | – |
| Q3 2021 | $250,000 | -4.2% | 40,435 | +22.8% | 0.00% | – |
| Q2 2021 | $261,000 | – | 32,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |